LVRLF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
6.46M
58 days until earnings call
MEDIF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
22.88M
Interact to see
Advertisement

LVRLF vs MEDIF

Header iconLVRLF vs MEDIF Comparison
Open Charts LVRLF vs MEDIFBanner chart's image
CordovaCann
Price$0.06
Change-$0.00 (-0.00%)
Volume$4.7K
Capitalization6.46M
Medipharm Labs
Price$0.05
Change-$0.00 (-0.00%)
Volume$48.26K
Capitalization22.88M
LVRLF vs MEDIF Comparison Chart in %
Loading...
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LVRLF vs. MEDIF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVRLF is a Hold and MEDIF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (LVRLF: $0.06 vs. MEDIF: $0.05)
Brand notoriety: LVRLF and MEDIF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LVRLF: 29% vs. MEDIF: 40%
Market capitalization -- LVRLF: $6.46M vs. MEDIF: $22.88M
LVRLF [@Pharmaceuticals: Generic] is valued at $6.46M. MEDIF’s [@Pharmaceuticals: Generic] market capitalization is $22.88M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LVRLF’s FA Score shows that 0 FA rating(s) are green whileMEDIF’s FA Score has 0 green FA rating(s).

  • LVRLF’s FA Score: 0 green, 5 red.
  • MEDIF’s FA Score: 0 green, 5 red.
According to our system of comparison, both LVRLF and MEDIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LVRLF’s TA Score shows that 4 TA indicator(s) are bullish while MEDIF’s TA Score has 3 bullish TA indicator(s).

  • LVRLF’s TA Score: 4 bullish, 3 bearish.
  • MEDIF’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, LVRLF is a better buy in the short-term than MEDIF.

Price Growth

LVRLF (@Pharmaceuticals: Generic) experienced а -1.92% price change this week, while MEDIF (@Pharmaceuticals: Generic) price change was -9.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

LVRLF is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEDIF($22.9M) has a higher market cap than LVRLF($6.46M). LVRLF YTD gains are higher at: 47.125 vs. MEDIF (25.327).
LVRLFMEDIFLVRLF / MEDIF
Capitalization6.46M22.9M28%
EBITDAN/A-4.75M-
Gain YTD47.12525.327186%
P/E RatioN/AN/A-
RevenueN/A43M-
Total CashN/A8.44M-
Total DebtN/A125K-
FUNDAMENTALS RATINGS
LVRLF vs MEDIF: Fundamental Ratings
LVRLF
MEDIF
OUTLOOK RATING
1..100
2762
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
6159
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MEDIF's Valuation (91) in the null industry is in the same range as LVRLF (97). This means that MEDIF’s stock grew similarly to LVRLF’s over the last 12 months.

MEDIF's Profit vs Risk Rating (100) in the null industry is in the same range as LVRLF (100). This means that MEDIF’s stock grew similarly to LVRLF’s over the last 12 months.

MEDIF's SMR Rating (95) in the null industry is in the same range as LVRLF (100). This means that MEDIF’s stock grew similarly to LVRLF’s over the last 12 months.

MEDIF's Price Growth Rating (59) in the null industry is in the same range as LVRLF (61). This means that MEDIF’s stock grew similarly to LVRLF’s over the last 12 months.

MEDIF's P/E Growth Rating (100) in the null industry is in the same range as LVRLF (100). This means that MEDIF’s stock grew similarly to LVRLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LVRLFMEDIF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LVRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGLCF0.17N/A
+2.73%
Cassiar Gold Corp.
MFCSF10.790.07
+0.67%
Medical Facilities Corp.
OSTIY15.59N/A
N/A
Osterreichische Post AG
BKAMF14.33N/A
N/A
BROOKFIELD CORP.
CLILF2.09N/A
N/A
Capitaland Investment Ltd.

LVRLF and

Correlation & Price change

A.I.dvisor tells us that LVRLF and GNMLF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LVRLF and GNMLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVRLF
1D Price
Change %
LVRLF100%
+1.96%
GNMLF - LVRLF
20%
Poorly correlated
N/A
MCUJF - LVRLF
14%
Poorly correlated
N/A
IPSEY - LVRLF
9%
Poorly correlated
+3.39%
MEDIF - LVRLF
8%
Poorly correlated
-1.26%
KSPHF - LVRLF
5%
Poorly correlated
N/A
More

MEDIF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MEDIF has been loosely correlated with CGC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDIF jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDIF
1D Price
Change %
MEDIF100%
-1.26%
CGC - MEDIF
36%
Loosely correlated
+5.80%
TLRY - MEDIF
28%
Poorly correlated
+3.48%
ACB - MEDIF
24%
Poorly correlated
+1.66%
AAWH - MEDIF
24%
Poorly correlated
+6.62%
GLASF - MEDIF
24%
Poorly correlated
+3.99%
More